Literature DB >> 31211237

FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin.

Fei Yang1, Yi Sun1,2.   

Abstract

F-box protein is a substrate-receptor of SKP1-Cullin1-F-box protein (SCF) E3 ligase, but the function of many family members remains elusive. We found that F-box and WD-repeat domain-containing 2 (FBXW2) inhibits proliferation and invasion of lung cancer cells by targeting S phase kinase-associated protein 2 (SKP2) and β-catenin for degradation. Lower FBXW2 predicts a worse patient survival. Thus, FBXW2 appears a lung tumor suppressor.

Entities:  

Keywords:  FBXW2; Lung cancer; SKP2; proliferation and invasion; ubiquitylation and degradation; β-catenin

Year:  2019        PMID: 31211237      PMCID: PMC6548489          DOI: 10.1080/23723556.2019.1607458

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  Systematic analysis and nomenclature of mammalian F-box proteins.

Authors:  Jianping Jin; Timothy Cardozo; Ruth C Lovering; Stephen J Elledge; Michele Pagano; J Wade Harper
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

Review 3.  The β-catenin destruction complex.

Authors:  Jennifer L Stamos; William I Weis
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

Review 4.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 5.  F-box protein interactions with the hallmark pathways in cancer.

Authors:  Suzanne J Randle; Heike Laman
Journal:  Semin Cancer Biol       Date:  2015-09-28       Impact factor: 15.707

Review 6.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.

Authors:  Roel Nusse; Hans Clevers
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

7.  Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia.

Authors:  Meng-Hsiu Chiang; Feng-Yu Liang; Chie-Pein Chen; Ching-Wen Chang; Mei-Leng Cheong; Liang-Jie Wang; Ching-Yeu Liang; Fang-Yu Lin; Chih-Chine Chou; Hungwen Chen
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.

Authors:  Jie Xu; Weihua Zhou; Fei Yang; Guoan Chen; Haomin Li; Yongchao Zhao; Pengyuan Liu; Hua Li; Mingjia Tan; Xiufang Xiong; Yi Sun
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

10.  FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation.

Authors:  Fei Yang; Jie Xu; Hua Li; Mingjia Tan; Xiufang Xiong; Yi Sun
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

  10 in total
  3 in total

1.  Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance.

Authors:  Chune Ren; Xue Han; Chao Lu; Tingting Yang; Pengyun Qiao; Yonghong Sun; Zhenhai Yu
Journal:  Cell Death Differ       Date:  2021-08-31       Impact factor: 12.067

Review 2.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

Review 3.  F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Authors:  Dinesh Singh Tekcham; Di Chen; Yu Liu; Ting Ling; Yi Zhang; Huan Chen; Wen Wang; Wuxiyar Otkur; Huan Qi; Tian Xia; Xiaolong Liu; Hai-Long Piao; Hongxu Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.